M
maka
I JUST READ THIS ,,,,,
On January 10, 2006, GlaxoSmithKline informed pharmacists and physicians about the limited availability of Coreg® (carvedilol) and Avandamet® (rosiglitazone maleate/metformin HCL). Coreg is indicated for the treatment of patients with heart failure or hypertension. It is also used in patients who had a heart attack to prevent further heart complications. Avandamet is a drug used to treat patients with diabetes. This shortage is not due to the quality of the manufactured tablets, either with tablets which are currently available or with those pending release. Instead it is due to the introduction of new documentation procedures that are necessary for product release from the Cidra, Puerto Rico manufacturing facility.
It is not known when supplies of these medicines will again be broadly available, although GSK is working to resolve these issues as quickly as possible. Until then, Medco By Mail may be out of stock of most strengths of Coreg and Avandamet. GSK may be able to arrange certain provisions for patients with severe heart failure, or post myocardial infarction with left ventricular dysfunction who are taking Coreg. Treatment options for these patients are limited. Patients currently taking Coreg or Avandamet should consult their healthcare professional about what actions they should take.
On January 10, 2006, GlaxoSmithKline informed pharmacists and physicians about the limited availability of Coreg® (carvedilol) and Avandamet® (rosiglitazone maleate/metformin HCL). Coreg is indicated for the treatment of patients with heart failure or hypertension. It is also used in patients who had a heart attack to prevent further heart complications. Avandamet is a drug used to treat patients with diabetes. This shortage is not due to the quality of the manufactured tablets, either with tablets which are currently available or with those pending release. Instead it is due to the introduction of new documentation procedures that are necessary for product release from the Cidra, Puerto Rico manufacturing facility.
It is not known when supplies of these medicines will again be broadly available, although GSK is working to resolve these issues as quickly as possible. Until then, Medco By Mail may be out of stock of most strengths of Coreg and Avandamet. GSK may be able to arrange certain provisions for patients with severe heart failure, or post myocardial infarction with left ventricular dysfunction who are taking Coreg. Treatment options for these patients are limited. Patients currently taking Coreg or Avandamet should consult their healthcare professional about what actions they should take.
It has been great for my mom. I was wondering-my mom is a new Medicare patient and has just signed up for a Blue Cross drug plan. She gets her meds at Wal Mart, and yesterday they gave her Coreg in a 14 day supply. I wonder was that Medicare or a shortage? The best part of that is that they charged her only 4 dollars!!
